Metraipolis › archive › dc_319bb96726cf
Effectiveness and safety of escitalopram treatment personalized based on therapeutic drug monitoring of drug plasma concentration: a prospective cohort study — Europe PMC PMID:40940437
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40940437
- DOI
- 10.1038/s41598-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T23:51:26.419Z
- SHA-256 of the archived text
fea0f6165b62183a021904d00b703dc87dba30f66f7853f7a62ceed1bef02d59- Stable URL of this page
https://metraipolis.com/documento/dc_319bb96726cf
How to cite
Effectiveness and safety of escitalopram treatment personalized based on therapeutic drug monitoring of drug plasma concentration: a prospective cohort study — Europe PMC PMID:40940437 — Europe PMC (en), https://europepmc.org/article/MED/40940437 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_319bb96726cf (Metraipolis archive dc_319bb96726cf, sha256 fea0f6165b62183a021904d00b703dc87dba30f66f7853f7a62ceed1bef02d59)
BibTeX
@misc{dc319bb96726cf,
title = {Effectiveness and safety of escitalopram treatment personalized based on therapeutic drug monitoring of drug plasma concentration: a prospective cohort study — Europe PMC PMID:40940437},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40940437},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_319bb96726cf; sha256 fea0f6165b62183a021904d00b703dc87dba30f66f7853f7a62ceed1bef02d59},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40940437. Agents can read the archived copy with the MCP tool read_document.